← DocG Medical Summaries
Top Rheumatology Research Papers
1.
8.2
Obexelimab for the Treatment of IgG4-Related Disease.
Overall: A rigorous phase 3 trial found a large reduction in clinically important flares and glucocorticoid exposure with manageable reported harms, offering practice-changing evidence despite weekly biologic-treatment burden.
2.
8.0
Phase 3 Trial of Secukinumab in Polymyalgia Rheumatica.
Overall: This randomized phase 3 trial shows a large, clinically meaningful steroid-sparing remission benefit in relapsed polymyalgia rheumatica, with similar serious adverse-event rates but added infection, access, and treatment burdens.
3.
7.2
Efficacy of Progressive Exercise Snacking for Middle-Aged and Older Adults With Knee Osteoarthritis: A Systematic Review and Meta-analysis.
Overall: This RCT meta-analysis suggests substantial short-term patient-centered benefits from a practical exercise strategy, but low-to-moderate certainty, waning effects, and uncertain long-term safety and effectiveness limit its practice-changing force.
4.
6.7
Tocilizumab Is Associated With a Lower Incidence of Major Adverse Cardiovascular Events in Giant Cell Arteritis.
Overall: This robust observational study reports a moderate reduction in hard cardiovascular outcomes, but residual confounding, absent safety data, and practical barriers limit its ability to change practice independently.
5.
6.1
Intravenous Immunoglobulin Add-On in Newly Diagnosed Idiopathic Inflammatory Myopathies: A Randomized Clinical Trial.
Overall: This small but rigorously controlled trial found substantially faster and greater composite improvement with add-on IVIG, although infusion burden, short follow-up, and limited safety precision constrain immediate practice change.
6.
6.1
Efficacy and Safety of Obinutuzumab in Active Systemic Lupus Erythematosus.
Overall: A rigorous trial found a large improvement in composite SLE response, but specialist administration, safety concerns, and limited direct evidence for patient-centered outcomes constrain its impact on routine US primary care.
7.
6.0
Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.
Overall: A rigorous systematic review demonstrates meaningful efficacy for several advanced rheumatoid arthritis therapies, but uncertain comparative safety and its specialist-centered decision point substantially limit its impact on US primary care.
8.
5.9
Effectiveness of a Biopsychosocial-Based Exercise Approach Delivered in Group and Individual Formats in Primary Sjögren Disease: A Randomized Controlled Trial.
Overall: This small randomized trial found clinically meaningful symptom improvement without reported adverse events, but its short follow-up and intensive delivery requirements make the evidence promising rather than immediately practice changing.
9.
5.7
Hydroxychloroquine for recurrent pericarditis: A multicentre observational study.
Overall: Hydroxychloroquine was associated with fewer recurrences, hospitalizations, and corticosteroid requirements, but the small uncontrolled before-and-after design prevents confident attribution of these improvements to treatment.
10.
5.7
Gout and Risk of Ischemic Stroke in Patients With Atrial Fibrillation: A Nationwide Cohort Study.
Overall: This large nationwide cohort links gout to a modest increase in ischemic stroke among patients with AF, but observational treatment findings and absent absolute benefit and safety data limit immediate practice change.
Score Guide:
9-10 Exceptional
7-8 Strong
5-6 Moderate
3-4 Weak
1-2 Poor
Top papers in other specialties
Emergency MedicineFamily Medicine / General Practice / Primary CareInternal MedicineAllergy & ImmunologyCardiologyDermatologyEndocrinologyGastroenterologyGeneticsGeriatricsHematologyInfectious DiseaseCritical CareNephrologyNeurologyObesityOccupational & Environmental HealthOncologyPain MedicinePalliative & Supportive CarePhysical Medicine & RehabilitationPsychiatryPublic HealthPulmonology/RespirologyObstetrics & GynecologyPediatricsAnesthesiologyOphthalmologyOtolaryngology (ENT)OrthopedicsUrologySurgery (Other)Sports MedicineAddiction Medicine